Fabio Majo

1.5k total citations
40 papers, 568 citations indexed

About

Fabio Majo is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, Fabio Majo has authored 40 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Fabio Majo's work include Cystic Fibrosis Research Advances (27 papers), Neonatal Respiratory Health Research (7 papers) and Tracheal and airway disorders (6 papers). Fabio Majo is often cited by papers focused on Cystic Fibrosis Research Advances (27 papers), Neonatal Respiratory Health Research (7 papers) and Tracheal and airway disorders (6 papers). Fabio Majo collaborates with scholars based in Italy, United States and France. Fabio Majo's co-authors include V. Lucidi, Valério Nobili, Claudia Della Corte, Anna Alisi, Antonella Mosca, Laura Stronati, Lidia Monti, Nadia Panera, B Delbosc and Enza Montemitro and has published in prestigious journals such as PLoS ONE, Scientific Reports and CHEST Journal.

In The Last Decade

Fabio Majo

38 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabio Majo Italy 14 299 147 120 117 54 40 568
Tamarah Katz Australia 16 561 1.9× 181 1.2× 142 1.2× 61 0.5× 56 1.0× 34 826
David Elphick United Kingdom 11 83 0.3× 185 1.3× 95 0.8× 94 0.8× 16 0.3× 20 523
Antônio Fernando Ribeiro Brazil 15 358 1.2× 69 0.5× 54 0.5× 77 0.7× 16 0.3× 43 527
Francesco De Peppo Italy 16 103 0.3× 317 2.2× 136 1.1× 136 1.2× 83 1.5× 45 632
Wolf‐Dietrich Huber Austria 15 62 0.2× 296 2.0× 47 0.4× 212 1.8× 37 0.7× 48 686
A. Giannattasio Italy 11 129 0.4× 73 0.5× 64 0.5× 44 0.4× 27 0.5× 22 341
Khin M. Gyi United Kingdom 12 575 1.9× 143 1.0× 86 0.7× 130 1.1× 59 1.1× 14 806
Rebecca Hill United Kingdom 10 75 0.3× 107 0.7× 109 0.9× 22 0.2× 44 0.8× 17 512
Tania Mahler Belgium 13 93 0.3× 455 3.1× 96 0.8× 65 0.6× 109 2.0× 23 719
Sheila G. McKenzie Switzerland 11 890 3.0× 133 0.9× 115 1.0× 102 0.9× 33 0.6× 14 1.1k

Countries citing papers authored by Fabio Majo

Since Specialization
Citations

This map shows the geographic impact of Fabio Majo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Majo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Majo more than expected).

Fields of papers citing papers by Fabio Majo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Majo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Majo. The network helps show where Fabio Majo may publish in the future.

Co-authorship network of co-authors of Fabio Majo

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Majo. A scholar is included among the top collaborators of Fabio Majo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Majo. Fabio Majo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cappa, Marco, Fabiana Ciciriello, Fabio Majo, et al.. (2025). Height Velocity in Pediatric Cystic Fibrosis Under Triple CFTR Modulator Therapy: A Real-Life Monocentric Experience. Journal of Clinical Medicine. 14(15). 5259–5259.
2.
Salvatore, Donatello, Paola Iacotucci, Angela Pepe, et al.. (2025). Real-world effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis patients with Phe508del -gating and -residual function genotypes. Respiratory Medicine. 245. 108221–108221. 1 indexed citations
3.
Cristiani, Luca, Fabio Majo, Nicola Ullmann, et al.. (2024). Use of Lung Ultrasound in Cystic Fibrosis: Is It a Valuable Tool?. Children. 11(8). 917–917.
4.
Albertos, Sonia, Fabio Majo, Rafael Esteban, Joan Colom, & Marı́a Buti. (2024). A large-scale screening of hepatitis C among men who have sex with men in the community using saliva point-of-care testing. Frontiers in Public Health. 12. 1478195–1478195. 1 indexed citations
5.
Graziano, Silvia, Fabio Majo, Enza Montemitro, et al.. (2023). P082 Is the new modulator affecting global health outcomes over time?. Journal of Cystic Fibrosis. 22. S88–S88. 1 indexed citations
6.
Boldrini, Francesca, Gaia Romana Pellicano, Fabio Majo, et al.. (2023). Longitudinal Effects of Elexacaftor/Tezacaftor/Ivacaftor. CHEST Journal. 165(4). 800–809. 17 indexed citations
7.
Marini, Giulia, et al.. (2023). Endotypes of Nasal Polyps in Children: A Multidisciplinary Approach. Journal of Personalized Medicine. 13(5). 707–707. 2 indexed citations
8.
Gramegna, Andrea, Fabio Majo, Gianfranco Alicandro, et al.. (2023). Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis. Respiratory Research. 24(1). 164–164. 14 indexed citations
9.
Salvatore, Donatello, Vincenzo Carnovale, Fabio Majo, et al.. (2020). Cystic fibrosis with non‐G551D gating mutations in Italy: Epidemiology and clinical characteristics. Pediatric Pulmonology. 56(2). 442–449. 3 indexed citations
10.
Salvatore, Donatello, Vito Terlizzi, Michela Francalanci, et al.. (2020). Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function. Respiratory Medicine. 171. 106073–106073. 24 indexed citations
11.
Pagani, Sara, Elena Bozzola, Vito Terlizzi, et al.. (2019). GH-IGF-1 Axis in Children with Cystic Fibrosis. Clinical Medicine & Research. 17(3-4). 82–89. 4 indexed citations
12.
Salvatore, Donatello, Rita Padoan, Roberto Buzzetti, et al.. (2018). Patients with cystic fibrosis having a residual function mutation: Data from the Italian registry. Pediatric Pulmonology. 54(2). 150–157. 11 indexed citations
13.
Amato, Annalisa, Fabio Majo, Gianluca Ferrari, et al.. (2018). [Italian Cystic Fibrosis Registry. Report 2011-2014].. PubMed. 42(1S1). 1–32. 8 indexed citations
14.
Corte, Claudia Della, Simona Faraci, Fabio Majo, et al.. (2018). Pancreatic disorders in children: New clues on the horizon. Digestive and Liver Disease. 50(9). 886–893. 8 indexed citations
15.
Buzzetti, Roberto, Natalia Cirilli, Fabio Majo, et al.. (2018). Defining research priorities in cystic fibrosis. Can existing knowledge and training in biomedical research affect the choice?. Journal of Cystic Fibrosis. 18(3). 378–381. 4 indexed citations
16.
Poerio, Noemi, Francesca Bugli, Francesco Taus, et al.. (2017). Liposomes loaded with bioactive lipids enhance antibacterial innate immunity irrespective of drug resistance. Scientific Reports. 7(1). 45120–45120. 29 indexed citations
17.
Sofia, Valentina, Cecilia Surace, Fabio Majo, et al.. (2015). Relationship between CFTR and CTRC Variants and the Clinical Phenotype in Late-Onset Cystic Fibrosis Disease with Chronic Pancreatitis. Journal of Molecular Diagnostics. 17(2). 171–178. 6 indexed citations
18.
Corte, Claudia Della, Danilo Fintini, Ugo Giordano, et al.. (2012). Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology. Clinical Endocrinology. 79(1). 49–54. 21 indexed citations
19.
Balaskas, Konstantinos, Fabio Majo, Christos Ikonomidis, & Yan Guex‐Crosier. (2011). Contribution of Serology in the Diagnosis of Cogan's Syndrome. Klinische Monatsblätter für Augenheilkunde. 228(4). 352–353. 1 indexed citations
20.
Algros, Marie‐Paule, Fabio Majo, Solange Bresson‐Hadni, et al.. (2003). Intracerebral Alveolar Echinococcosis. Infection. 31(1). 63–65. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamarah Katz Breakdown of academic impact, for papers by David Elphick Breakdown of academic impact, for papers by Antônio Fernando Ribeiro Breakdown of academic impact, for papers by Francesco De Peppo Breakdown of academic impact, for papers by Wolf‐Dietrich Huber Breakdown of academic impact, for papers by A. Giannattasio Breakdown of academic impact, for papers by Khin M. Gyi Breakdown of academic impact, for papers by Rebecca Hill Breakdown of academic impact, for papers by Tania Mahler Breakdown of academic impact, for papers by Sheila G. McKenzie
Rankless by CCL
2026